Immuron Limited announced that CEO Steven Lydeamore will present at the TechKnow Invest Roadshow in Melbourne, Australia, on July 27, 2026. The presentation is part of the company's ongoing investor engagement efforts. Immuron is a biopharmaceutical company that develops and commercializes orally delivered targeted polyclonal antibodies for treating infectious diseases.
